AngioDynamics to Present at the Canaccord Adams Global Growth ConferenceQUEENSBURY, N.Y.--(BUSINESS WIRE)--July 31, 2007--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the Canaccord Adams Global Growth Conference at the InterContinental Hotel in Boston, Massachusetts on Tuesday, August 7, 2007. AngioDynamics' Management will review the Company's business strategy and historical financial results at 4:00 p.m. local time.

Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company's website at: www.angiodynamics.com.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

    CONTACT: AngioDynamics, Inc.
             Joseph Gersuk, CFO, 800-772-6446 ext. 1608
             jgersuk@AngioDynamics.com
             or
             EVC Group, Inc.
             Jennifer Beugelmans/Doug Sherk, 646-201-5447
             (Investor Relations)
             jbeugelmans@evcgroup.com
             dsherk@evcgroup.com
             Steve DiMattia, 646-201-5445 (Media)
             sdimattia@evcgroup.com

    SOURCE: AngioDynamics, Inc.